Individual differences in average evoked responses to d- and l-amphetamine with and without lithium carbonate in depressed patients. 1977

M S Buchsbaum, and D P van Kammen, and D L Murphy

Visual average evoked responses (AERs) to four intensities of light were studied in hospitalized depressed patients receiving placebo, d-amphetamine, l-amphetamine, lithium and d- and l-amphetamine combined with lithium. For the assessment of the subjective effects of the drugs, the patients completed a 34-item mood and behavior self-rating scale. AER responses to repeated doses of the amphetamines were consistent within the same individual but varied greatly between different individuals. For the patient group considered as a whole, only minor AER changes occurred in response to either d- or l-amphetamine; nonetheless, these minor changes were attenuated by lithium co-administration. There were indications, however, that AER baseline measures could be used as predictors of change in self-rating due to both d- and l-amphetamine, as patients who had larger AER amplitudes on baseline also tended to have larger increases in activation ratings and reductions in depression ratings. The amount of increase in AER amplitude or amplitude/intensity slope seen with amphetamine was also significantly correlated with the amount of increase in activation or euphoria ratings with amphetamine administration. These effects were most prominent in the same P100 component that we have previously found to differentiate bipolar and unipolar depressed patient groups.

UI MeSH Term Description Entries
D008094 Lithium An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER. Lithium-7,Lithium 7
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D010775 Photic Stimulation Investigative technique commonly used during ELECTROENCEPHALOGRAPHY in which a series of bright light flashes or visual patterns are used to elicit brain activity. Stimulation, Photic,Visual Stimulation,Photic Stimulations,Stimulation, Visual,Stimulations, Photic,Stimulations, Visual,Visual Stimulations
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D003913 Dextroamphetamine The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic. d-Amphetamine,Curban,Dexamfetamine,Dexamphetamine,Dexedrine,Dextro-Amphetamine Sulfate,DextroStat,Dextroamphetamine Sulfate,Oxydess,d-Amphetamine Sulfate,dextro-Amphetamine,Dextro Amphetamine Sulfate,Sulfate, Dextroamphetamine,d Amphetamine,d Amphetamine Sulfate,dextro Amphetamine
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug

Related Publications

M S Buchsbaum, and D P van Kammen, and D L Murphy
April 2001, Alcoholism, clinical and experimental research,
M S Buchsbaum, and D P van Kammen, and D L Murphy
November 1975, Psychopharmacologia,
M S Buchsbaum, and D P van Kammen, and D L Murphy
December 1973, Archives of general psychiatry,
M S Buchsbaum, and D P van Kammen, and D L Murphy
April 1981, Biological psychiatry,
M S Buchsbaum, and D P van Kammen, and D L Murphy
April 2016, Journal of psychopharmacology (Oxford, England),
M S Buchsbaum, and D P van Kammen, and D L Murphy
January 1976, Psychosomatic medicine,
M S Buchsbaum, and D P van Kammen, and D L Murphy
August 1991, Journal of clinical psychopharmacology,
M S Buchsbaum, and D P van Kammen, and D L Murphy
January 1970, Acta psychiatrica Scandinavica,
Copied contents to your clipboard!